Chicago’s MDL 3060 aggregates uterine, endometrial, and ovarian cancer claims tied to chemical straighteners. Skim bellwether mechanics, defendant lists, and what product-use histories reviewers typically ask for—without recycled “latest lawsuit news” filler.
Last updated: May 13, 2026
No. 3060 (N.D. Ill.)
Hon. Mary M. Rowland
11,000+ pending
Bellwether trials; litigation ongoing
Plaintiffs in MDL 3060 argue cumulative relaxer use altered hormone-sensitive tissue while labels understated risk. Coordinated discovery covers formulation chemistry, marketing to Black women, and expert path opinions—settlements, if any, would still require individual proof of harm.
Hair relaxer litigation is centralized in In re: Hair Relaxer Marketing Sales Practices and Products Liability Litigation, MDL No. 3060, in the Northern District of Illinois before Judge Mary M. Rowland. This consolidation streamlines discovery, bellwether selection, and rulings on common legal and scientific issues. Plaintiffs allege that long-term use of chemical hair relaxers or straighteners increased their risk of uterine cancer, endometrial cancer, or ovarian cancer and that manufacturers failed to adequately warn about the risks.
An MDL is different from a class action. In the MDL, each plaintiff keeps an individual case and any settlement or verdict is based on that person's injuries and damages. This structure typically allows for higher compensation for those with more severe harm. A separate class action exists regarding product reimbursement; the cancer injury claims are individual cases in the MDL.
| Date / Period | Development |
|---|---|
| 2022 | NIH study finds 2.55x higher risk of uterine cancer with frequent use of chemical hair straighteners; litigation filings increase. |
| 2023–2024 | MDL formed; cases centralized in Northern District of Illinois. Bellwether process begins. |
| 2025–2026 | Bellwether cases selected for discovery and trial consideration; first bellwether trials expected. Litigation remains in pretrial phase. |
| Ongoing | New hair relaxer lawsuits continue to be filed; no global settlement yet. |
Peer-reviewed research has contributed to the litigation. Courts and plaintiffs rely on this evidence when evaluating failure-to-warn and causation. Key points include:
If you used chemical hair relaxers or straighteners and were diagnosed with uterine cancer, endometrial cancer, or ovarian cancer, you may be eligible for a free case review. Get the full picture on eligibility and how to get connected with a law firm.
Hair Relaxer Lawsuit – Free Case ReviewFree, confidential case review. No obligation. We may connect you with an independent law firm if appropriate.
Start Free Case ReviewThis hair relaxer lawsuit news page is for informational purposes only and does not constitute legal advice. Top Tier Legal LLC is not a law firm. Litigation status and dates may change. For the most current hair relaxer lawsuit update and to see if you qualify for a free case review, visit our Hair Relaxer lawsuit page or contact us.